Investigational drug for treating metastatic pancreatic cancer
- Trial ID:
- IRB-22-8008
- Darren Sigal, M.D.
Inclusion Criteria
*Have pathologically diagnosed locally advanced or metastatic pancreatic adenocarcinoma (mPDAC)*Be willing to submit an archived or fresh tumor specimen for central testing
*Have normal organ function
*Be over the age of 18 years old
Contact Info:
- Clinical Research Services
- CRSLeadership@scrippshealth.org